According to the European prenatal health survey [44] , there is an increasing trend for advanced maternal age in pregnancy, and the frequency of developing PE is approximately 6–8% among women above 40 years.
← all excerpts
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.
1
—
—